Join
Live feed
·
PRReleasevia Quantisnow
Veru Inc. logo

Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

ByQuantisnow·Wall Street's wire, on your screen.
VERU· Veru Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERU (Veru Inc.) and more on Quantisnow.